Abstract
The development of chlamydial vaccines is generally considered desirable since C. trachomatis and C. psittaci are common pathogens and chlamydial infections can result in severe complications. The prospectives for such vaccines from a molecular standpoint have recently been discussed by Ward and associates (1988). Until recently, C. trachomatis vaccine studies and trials mainly focused on prevention of trachoma. Some of these study groups progressed to human field trials (Grayston et al., 1964; Guerra et al., 1967; Soldati et al., 1971; Grayston, 1971; Nichols and Snyder, 1971; Bietti et al., 1972; Collier, 1972). However, because the results were not promising, trachoma prevention is now being approached mainly by other means, i.e., by education and treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Publishing Corporation
About this chapter
Cite this chapter
Mårdh, PA., Paavonen, J., Puolakkainen, M. (1989). Vaccines. In: Chlamydia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0719-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0719-8_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8048-4
Online ISBN: 978-1-4613-0719-8
eBook Packages: Springer Book Archive